Washington University School of Medicine - Siteman Cancer Center — St Louis, Missouri

Washington University School of Medicine - Siteman Cancer Center is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Washington University School of Medicine - Siteman Cancer Center has participated in 40 clinical trials with 22 currently active.

Therapeutic areas: Metastatic Breast Cancer, Retroperitoneal Sarcoma, Liposarcoma.

Sponsors: Gilead Sciences, European Organisation for Research and Treatment of Cancer - EORTC, Pfizer.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine - Siteman Cancer Center?

Washington University School of Medicine - Siteman Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine - Siteman Cancer Center conducted?

Washington University School of Medicine - Siteman Cancer Center has 40 clinical trials on record, with 22 currently active. Their work covers Metastatic Breast Cancer, Retroperitoneal Sarcoma, Liposarcoma.

Is Washington University School of Medicine - Siteman Cancer Center accredited by Crixeo Health?

Washington University School of Medicine - Siteman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine - Siteman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.